logo

Search

Login | Create Account

rheumatology


Categories

Bone health Gout JIA Lupus Medicines Medicopolitical Musculoskeletal Osteoarthritis Pain Psoriatic arthritis Public health Rare diseases Research Rheumatoid arthritis Risk factors Scleroderma Spondyloarthritis

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

EULAR 2020

Thursday 1st - Thursday 1st January 1970

Medicopolitical

Pioneer of nurse-led rheumatology offers a template for Australia

Nurse-led practice in rheumatology has become commonplace in many parts of the world in response to a shortage of rheumatologists and the rising burden of disease.  But in Australia it is pioneering stuff. A veteran of 20 years in rheumatology, Nurse...

Nurse-led practice in rheumatology has become commonplace in many parts of the world in response to a shortage of rheumatologists...


Lupus

Low medication persistence rates in lupus show need for more effective therapies

The churn rate through most lupus medications supports other evidence that there is an unmet need for new therapies. That’s one of the take home messages from an analysis of medication use between 2013 and 2018 from the Asia Pacific Lupus...

The churn rate through most lupus medications supports other evidence that there is an unmet need for new therapies. That’s one...


Rheumatoid arthritis

Australian rheumatologists are rapid adopters of JAK inhibitors in RA

JAK inhibitors have been adopted with enthusiasm by Australian rheumatologists for the treatment of RA since they became available in 2015, according to figures from the OPAL (Optimising Patient outcomes in Australian rheumatoLogy) dataset. About one in four patients with RA...

JAK inhibitors have been adopted with enthusiasm by Australian rheumatologists for the treatment of RA since they became available in...


Cancel
Cancel